Investigation of motility and biofilm formation by intestinal Campylobacter concisus strains
© Lavrencic et al.; licensee BioMed Central Ltd. 2012
Received: 26 November 2012
Accepted: 13 December 2012
Published: 14 December 2012
Motility helps many pathogens swim through the highly viscous intestinal mucus. Given the differing outcomes of Campylobacter concisus infection, the motility of eight C. concisus strains isolated from patients with Crohn’s disease (n=3), acute (n=3) and chronic (n=1) gastroenteritis and a healthy control (n=1) were compared. Following growth on solid or liquid media the eight strains formed two groups; however, the type of growth medium did not affect motility. In contrast, following growth in viscous liquid medium seven of the eight strains demonstrated significantly decreased motility. In media of increasing viscosities the motility of C. concisus UNSWCD had two marked increases at viscosities of 20.0 and 74.7 centipoises. Determination of the ability of UNSWCD to swim through a viscous medium, adhere to and invade intestinal epithelial cells showed that while adherence levels significantly decreased with increasing viscosity, invasion levels did not significantly change. In contrast, adherence to and invasion of UNSWCD to mucus-producing intestinal cells increased upon accumulation of mucus, as did bacterial aggregation. Given this aggregation, we determined the ability of the eight C. concisus strains to form biofilms, and showed that all strains formed biofilms. In conclusion, the finding that C. concisus strains could be differentiated into two groups based on their motility may suggest that strains with high motility have an increased ability to swim through the intestinal mucus and reach the epithelial layer.
KeywordsCampylobacter concisus Motility Adherence Viscous Mucus Biofilm
Campylobacter jejuni and Campylobacter coli are the most common cause of acute bacterial gastroenteritis world-wide and as a result, they are the most widely studied Campylobacter species . In recent years, a number of other Campylobacter species, including Campylobacter concisus, have emerged as gastrointestinal pathogens [2–4]. For example, C. concisus has been isolated from faecal samples and colonic intestinal biopsies of patients with both acute and chronic gastroenteritis and Crohn’s disease [5, 6]. Although in comparison to C. jejuni relatively little is known about C. concisus, studies have shown that they share a number of similarities . While both bacteria are spiral shaped and flagellated, C. jejuni can have single or bi-polar flagella, whereas C. concisus only has a single polar flagellum.
Bacterial flagella are complex, highly refined organelles that allow bacteria to swim through fluids, including viscous environments, and which also play a central role in adhesion to and invasion into host cells . In the well-established pathogen C. jejuni, flagellar motility has been reported to be a key pathogenicity factor , with early studies showing that C. jejuni was capable of colonising the mucus layer and intestinal crypts filled with mucus . Further, the flagellum of C. jejuni has been shown to assist in bacterial adhesion to epithelial cells . Scanning electron microscopy (ScEM) studies have shown that C. concisus adheres to the intestinal epithelium by wrapping its flagellum around the microvilli of intestinal epithelial cells [5, 12]. Although the importance of motility in C. concisus has yet to be described, current data would suggest that the flagellum may be an important pathogenicity factor in C. concisus infection [5, 12].
Bacterial flagella have also been shown to be involved in biofilm formation [13, 14]. The ability to form biofilms through the complex interaction of bacteria has been reported to be important for bacterial survival within the human host. A key feature of biofilms in bacterial survival is self-defence. Although bacteria infecting the human body stimulate both an innate and adaptive immune response, neither of these is capable of penetrating and eliminating bacteria within the well-established biofilm . C. concisus ATCC 33237, a human gingival isolate, has also been shown to form biofilms in vitro.
In some bacteria the flagellin protein of the flagellum has been reported to be heavily glycosylated , with studies showing that C. jejuni and C. coli strains contain flagellin glycosylation biosynthesis pathways for the synthesis of two sugars, pseudaminic acid (PA)  and legionaminic acid (LA) . Interestingly, studies of C. jejuni and C. coli have shown that the flagellum mediates auto-agglutination of flagellin glycans [17, 18]. It has been postulated that the close proximity of bacteria allows them to interact with adjacent flagella initiating auto-agglutination, aggregation, and the formation of micro-colonies . In a recent study investigating the type of glycosylation pathways in eight strains of C. concisus, we showed that seven of the eight C. concisus strains contained proteins for the PA pathway, while one strain contained the LA pathway . Thus, it is possible that differences may exist between C. concisus strains in their ability to auto-agglutinate their flagellin glycans.
In this study, the motility of eight C. concisus strains found to have different virulence potential was determined following growth on three different medium types, and the effects of viscosity on C. concisus motility and pathogenesis was elucidated. Moreover, the ability of these eight C. concisus strains to form biofilms was assessed.
Materials and methods
Bacterial strains and growth conditions
Eight C. concisus strains that had been previously isolated from patients with a range of intestinal diseases  were included in this study. C. concisus strains UNSWCD, UNSW2, UNSW3 (Crohn’s disease), UNSW1 (chronic gastroenteritis), ATCC 51561 (healthy subject), ATCC 51562, UNSWCS and BAA 1457 (acute gastroenteritis) were grown on Horse Blood Agar (HBA) plates [Blood Agar Base No. 2 supplemented with 6% defibrinated horse blood (Oxoid; Heidelberg West, VIC, Australia)], and incubated at 37°C under microaerobic conditions with H2 [generated using Campylobacter Gas Generating Kits (Cat. #. BR0056A, Oxoid)] for 24 h.
To evaluate motility following growth in liquid medium, the eight C. concisus strains were first grown on HBA plates for 24 h, harvested and then transferred to individual 10 ml Brain Heart Infusion (BHI) broths (Oxoid) containing 10% Foetal Bovine Serum (FBS) (Interpath; Heidelberg West, VIC, Australia), and where relevant, a known concentration of carboxy-methyl-cellulose (CMC) (Sigma-Aldrich; Castle Hill, NSW, Australia) that corresponded to a particular viscosity (, Additional file 1). The broths were then incubated for 24 h under microaerobic conditions at 37°C.
C. concisus cultures were centrifuged at 3,619 × g for 5 min and the cell pellets resuspended in 500 μl of PBS. The OD was then measured at 595 nm, and the OD adjusted to 0.5 (optimisation of the OD value is presented in Additional file 2). To conduct the motility assay, semi-solid serum plates (20 ml) [28 g Brucella broth (BD), 3.5 g Bacteriological Agar No. 1 (Oxoid) and 10% FBS] were inoculated with bacteria (3.8 μl), and then incubated at 37°C under microaerobic conditions for 72 h. After 72 h of incubation, a zone of motility was observed around the inoculation point, which represented the distance that the bacteria had migrated.
Mammalian cell culture
Two cell lines were used in this study, the human intestinal epithelial cell line Caco-2 (American Type Culture Collection; HTB-37) and the human mucin producing intestinal cell line LS174T (American Type Culture Collection; CL-188).
Caco-2 cells were grown in 10 ml cell culture medium comprised of Minimum Essential Medium (MEM), (Invitrogen; Mulgrave, VIC, Australia) supplemented with 10% FBS, 1 mM sodium pyruvate, 0.1 mM non-essential amino acids, 2.25 mg 1-1 sodium bicarbonate and 100 μg ml-1 penicillin and streptomycin (Invitrogen) in 25 cm2 tissue culture flasks (In Vitro Technologies; Noble Park, VIC, Australia) at 37°C with 5% CO2. Cells were seeded at a concentration of 5 × 105 cells ml-1 into 24-well plates and kept for 2 days at 37°C with 5% CO2 in order to form a confluent monolayer (confirmed visually) for the adherence and invasion assays. Prior to seeding, the wells were coated with 1 ml collagen (0.338 mg ml-1) and incubated for 20 min at 37°C with 5% CO2.
LS174T cells were grown in 10 ml cell culture medium comprising Roswell Park Memorial Institute (RPMI)-1640 medium (Invitrogen) supplemented with 10% FBS and 100 μg ml-1 penicillin and streptomycin in 25 cm2 tissue culture flasks at 37°C with 5% CO2. Cells were seeded at a concentration of 5 × 105 cells ml-1 into 24-well plates and kept for 2 days to form a confluent monolayer (confirmed visually) (0-day time point). The confluent monolayer was incubated at 37°C with 5% CO2 for an extra 2 days to allow the development of a mucin layer (confirmed visually) for the adherence and invasion assays (2-day time point). The medium was changed daily until the development of a mucin layer.
Gentamicin protection (invasion) and adherence assays
Following incubation, the seeded cells in each well were washed twice with 1 ml of the relevant antibiotic-free medium, after which 1 ml of antibiotic-free medium with CMC at a concentration of 0 centipoise (cp), 20 cp or 74 cp (Caco-2 cells only) were aliquoted into the seeded wells. Monolayers were inoculated with C. concisus UNSWCD at a multiplicity of infection (MOI) of 200. Infected monolayers were then co-incubated with the bacteria for 6 h at 37°C with 5% CO2 to allow adherence and invasion to occur. Invasion and adherence assays were then performed as previously described by Kaakoush et al.. Bacterial adherence was calculated by subtracting the internalized bacteria determined using the gentamicin protection assay from the bacterial counts obtained using the adherence assay, and expressed as a relative percentage of inoculated bacteria.
Western blot analysis
LS174T cells were seeded at 5 × 105 cells ml-1 in 24-well plates and incubated at 37°C. After 2 days the cells were lysed and collected using 400 μl radioimmunoprecipitation (RIPA) buffer. A bicinchoninic acid assay was used to determine the protein concentration for each cell lysis sample collected. OD values were measured at 595 nm using the Bio-Rad 8550 Microplate Reader (Bio-Rad; Gladesville, NSW, Australia).
Proteins were then separated on 12% SDS-PAGE gels, and transferred to methanol-treated polyvinylidine difluoride membranes with use of the Trans-blot cell transfer system (Bio-Rad). Membranes were probed in accordance with the Immun-StarWesternC Kit protocol (Bio-Rad). Membranes were immunolabeled with mouse monoclonal antibodies against Mucin-1 (MUC1) (1:200), Mucin-2 (MUC2) (1:200), or β-actin (1:1000) (Santa Cruz Biotechnology Inc.; Santa Cruz, CA, USA). Goat anti-mouse IgG antibodies coupled to HRP (1:2000; Bio-Rad) were used as a secondary antibody. Bands were visualized and quantified using a LAS-3000 (Fujifilm; Brookvale, NSW, Australia).
Measurement of Biofilm formation by Campylobacter concisus
C. concisus strains were grown on HBA plates for 24 h, after which the bacteria were harvested, resuspended and the OD measured at 595 nm. The OD was then adjusted with PBS to 0.5. Two aliquots of the harvested bacteria, each of 150 μl, were then evenly distributed over two cover slips in a glass petri dish containing 5 ml BHI supplemented with 10% FBS. The glass petri dish was then incubated at 37°C under microaerobic conditions for 72 h. After 72 h, the medium was carefully removed and the petri dish washed gently with 2 ml of PBS to remove planktonic bacteria. The petri dish was then placed into an 80°C oven for 30 min to heat fix any biofilm formed. A 3 ml aliquot of 0.1% crystal violet (Oxoid) was then added to the petri dish and this was left to stain for 1 h at room temperature. After 1 h, the crystal violet was removed with a pipette and the petri dish was vigorously washed with 2 ml of PBS to remove any excess crystal violet stain. Following this, 2 ml of 95% ethanol was added to the petri dish until all the stain was dissolved. The OD of the dissolved biofilm inside the petri dish was measured at 595 nm. In each experiment a negative control (no bacteria) was included to account for non-specific binding of the stain.
In order to perform statistical analyses on the data, all experiments were repeated a minimum of three times, with each biological replicate consisting of two technical replicates. Analysis of Variance (ANOVA) was conducted using Minitab 184.108.40.206 (Minitab Inc.; State College, PA, USA) for all statistical studies conducted, with the significance level set at p < 0.05. The data were checked to ensure that it fitted the assumptions of ANOVA including homogeneity of variance and normal distribution. Tukey’s post hoc-multiple comparisons were conducted where significant differences were found. To determine if prior growth on the three different media types affected the motility of the eight C. concisus strains, a two-way ANOVA was conducted. In the statistical model, strain and medium were set as fixed factors, and the interaction of these factors were tested. A one-way ANOVA was performed for all other statistical analyses within this study.
Results and discussion
Motility of the eight Campylobacter concisus strains
Motility of the eight Campylobacter concisus strains grown in viscous medium
The colonic mucus is composed of two semipermeable layers totalling a thickness of 800 μm . The top layer of mucus is less viscous (approximately 20 cp), is much thicker and is normally colonised by commensal bacteria . In comparison, the bottom layer is denser, thinner and much more elastic giving the layer properties that make it impermeable to normal commensal bacteria . Given this, we were interested in determining the effect on bacterial motility following growth in a viscous liquid, as this would mimic to some degree the viscosity encountered in the host, where prior to reaching the intestinal epithelium, the bacteria must move through the intestinal mucus layers that act as a barrier against many pathogens. Due to the lack of homogeneity of the two mucus layers, many in vitro studies have used CMC to estimate bacterial motility through an intestinal mucus-like medium [9, 23]. The advantages of CMC are that it is non-toxic to tissue culture and bacterial cells, is more chemically defined than purified human mucin, and can be easily manipulated to create the desired viscosity; however, it remains an artificial compound that does not mimic the complex environment within the intestinal tract.
Motility of Campylobacter concisus UNSWCD following culture in varying viscosities
Interestingly, two peaks of motility have also been reported in C. jejuni which has been postulated to represent an adaptation that assists C. jejuni to reach the intestinal epithelial surface . Shigematsu et al. suggested that the first increase in velocity was predominantly due to the bacterium’s flagella propelling the motion , while the second increase in motility they suggested was due predominantly to the spiral shape of the bacterium. In comparison, this same study showed the motility of the well-established pathogen Salmonella enterica Serovar Typhimurium had only one peak of motility at 1.5 cp after which the velocity decreased dramatically as the viscosity increased . Interestingly, although S. Typhimurium is flagellated, it does not have a spiral body like C. jejuni and C. concisus.
Campylobacter concisus adherence and invasion into host cells in a viscous environment
Szymanski et al. have previously shown that as viscosity increases from 0 to 141 cp, adherence to and invasion of C. jejuni to Caco-2 epithelial cells significantly increases (p < 0.05). Thus, we considered it possible that C. concisus may show a similar trend. To test this, adherence and invasion assays were performed with the addition of medium at two different viscosity levels following culture of the Caco-2 cells. The two viscosities chosen, 20.0 cp and 74.7 cp, were based on the two peak motilities shown in our studies examining the effect of viscosity on C. concisus UNSWCD motility (Figure 3). A control containing medium alone (no CMC) was also examined. The results of the adherence assay showed that C. concisus UNSWCD at zero viscosity (0 cp) adhered to Caco-2 cells at a similar level (6.01 ± 0.33%) to that previously reported in a study where centrifugation was used . A finding that would suggest that for UNSWCD centrifugation may not be a necessary step for adherence. At a viscosity of 20.0 cp, C. concisus adherence was reduced (4.48 ± 0.53%) and at 74.7 cp it decreased even more (3.48 ± 0.50%) (F2,21 = 8.9, p = 0.0015). Similar to the adherence assay, the invasion level of C. concisus into Caco-2 cells in the absence of centrifugation (0.56 ± 0.08%), was again similar to that reported in a previous study where centrifugation was included (0.47 ± 0.04%) . When the viscosity was increased to 20.0 cp and 74.7 cp, invasion of C. concisus into Caco-2 cells remained the same (0.51 ± 0.07% and 0.50 ± 0.09%, respectively) and did not differ from the control (F2,6 = 0.17, p = 0.84). The observed reduction in C. concisus adherence to Caco-2 cells upon exposure to viscous medium is consistent with the hypothesis that C. concisus may upregulate auto-agglutination upon mechanosensing the viscous environment.
Given this, we determined using adherence and invasion assays the ability of C. concisus UNSWCD to adhere to and invade LS174T cells at day 0 and 2. We observed that the percentage of C. concisus UNSWCD adhering to LS174T cells increased from 4.61 ± 0.44% at day 0 to 8.20 ± 0.50% at day 2 (1.8-fold increase, p = 0.0036). Interestingly, the percentage of C. concisus UNSWCD that invaded LS174T cells also increased 1.8-fold from day 0 to day 2, although overall the levels of invasion were significantly lower than those observed for Caco-2 cells (~50-fold lower). One possible reason for the increased adherence with increase in mucus is the chemoattractive properties of mucins. For example, Hugdahl et al. have reported positive chemotaxis by C. jejuni towards mucin . Alternatively, C. concisus may bind to mucins to help facilitate adhesion to LS174T cells. Interestingly, a study by McAuley et al. has shown that C. jejuni binds to oligosaccharide ligands on the surface of mucins using adhesins . Collectively, the increase in adherence of C. concisus to the surface of LS174T cells may be due to the interplay between the chemoattractive property of mucins along with the ability of C. concisus to bind to mucin structures.
While the observed increase in invasion may have resulted from increased adherence, another explanation could be that exposure to mucus also modulates the invasive potential of C. concisus. For example, Tu et al. have reported that exposure of C. jejuni to mucin results in the upregulation of the Campylobacter invasion antigen ciaB that allows the internalisation of C. jejuni into mammalian cells, and that cadF which encodes fibronectin binding protein facilitates binding to host fibronectin and allows adhesion to the surface of host cells . These proteins are also encoded by C. concisus UNSWCD , and whilst studies involving the change in gene expression of C. concisus in the presence of mucus have not been conducted, the study in C. jejuni raises the possibility that C. concisus UNSWCD gene regulation may also occur in the presence of mucus.
Our results with the LS174T cell line are consistent with changes in pathogenic potential of C. jejuni in viscous environments, although they do not explain the drop in adherence observed with addition of CMC. One possible reason for this is that unlike CMC, mucus is chemoattractive and bacteria bind to mucins. An alternate explanation is that in the CMC experiments the whole medium (~ 1 cm in height) is viscous, thus, the bacteria are exposed to viscosity directly upon inoculation, whereas in the mucus cell line bacteria are only exposed to the viscous environment (~800 μm in height) upon swimming down to the cells.
Biofilm formation by Campylobacter concisus
Given that biofilm formation is reported to assist in bacterial survival, colonisation and protection from host immune responses and antibacterial therapies , the ability of C. concisus to form biofilms may represent an important virulence mechanism in relation to its pathogenesis and transmission. Interestingly, based on an observation that an increased level of biofilm formation occurs in C. jejuni when incubated under aerobic conditions, Reuter et al. suggested that biofilms may aid the survival of C. jejuni in the environment, and that this adaptation may contribute to its zoonotic lifestyle . While currently it is unknown whether C. concisus is a zoonotic infection, the possibility has been raised by the detection of C. concisus in cats, dogs, chickens and cattle . In relation to survival within the host, our observation of biofilm like aggregations following infection of intestinal cells with C. concisus raises the possibility that like uropathogenic E. coli UTI89, biofilm formation may be a critical factor contributing to a persistent infection in the human host . Given that within the intestinal tract C. concisus is continually subjected to peristalsis and mucus turn-over, the ability to produce biofilms may allow the bacterium to remain within its niche.
Evidence suggests that both animals and the oral cavity of humans provide a reservoir of C. concisus that could pass into the intestinal tract of humans following ingestion. Based on the results of this study, we hypothesise that strains with higher motility have a greater chance to swim through the intestinal mucus layer and reach the epithelial surface. Once adhered to the epithelium through their flagellum, strains with the proper pathogenicity factors such as the exotoxin 9, which has been associated with the invasive potential of C. concisus, can invade into the host cell, induce an inflammatory response, and subsequently, cause disease.
This work was made possible by the support of the National Health and Medical Research Council, Australia and the University of New South Wales Silver star award. NOK is supported by an Early Career Fellowship from the National Health and Medical Research Council, Australia.
- Moore JE, Corcoran D, Dooley JS, Fanning S, Lucey B, Matsuda M, McDowell DA, Megraud F, Millar BC, O’Mahony R, O’Riordan L, O’Rourke M, Rao JR, Rooney PJ, Sails A, Whyte P: Campylobacter. Vet Res. 2005, 36: 351-382. 10.1051/vetres:2005012.View ArticlePubMed
- Gorkiewicz G, Feierl G, Zechner R, Zechner EL: Transmission of Campylobacter hyointestinalis from a pig to a human. J Clin Microbiol. 2002, 40: 2601-2605. 10.1128/JCM.40.7.2601-2605.2002.PubMed CentralView ArticlePubMed
- Kaakoush NO, Mitchell HM: Campylobacter concisus - a New player in intestinal disease. Front Cell Infect Microbiol. 2012, 2: 4.PubMed CentralView ArticlePubMed
- Nielsen HL, Ejlertsen T, Engberg J, Nielsen H: High incidence of Campylobacter concisus in gastroenteritis in North Jutland, Denmark: a population-based study. Clin Microbiol Infect. 2012, 10.1111/j.1469-0691.2012.03852.x.
- Kaakoush NO, Deshpande NP, Wilkins MR, Tan CG, Burgos-Portugal JA, Raftery MJ, Day AS, Lemberg DA, Mitchell H: The pathogenic potential of Campylobacter concisus strains associated with chronic intestinal diseases. PLoS One. 2011, 6: e29045-10.1371/journal.pone.0029045.PubMed CentralView ArticlePubMed
- Vandamme P, Falsen E, Pot B, Hoste B, Kersters K, De Ley J: Identification of EF group 22 campylobacters from gastroenteritis cases as Campylobacter concisus. J Clin Microbiol. 1989, 27: 1775-1781.PubMed CentralPubMed
- Nielsen HL, Engberg J, Ejlertsen T, Bucker R, Nielsen H: Short-term and medium-term clinical outcomes of Campylobacter concisus infection. Clin Microbiol Infect. 2012, 18: E459-E465. 10.1111/j.1469-0691.2012.03990.x.View ArticlePubMed
- Ramos HC, Rumbo M, Sirard JC: Bacterial flagellins: mediators of pathogenicity and host immune responses in mucosa. Trends Microbiol. 2004, 12: 509-517. 10.1016/j.tim.2004.09.002.View ArticlePubMed
- Szymanski CM, King M, Haardt M, Armstrong GD: Campylobacter jejuni motility and invasion of Caco-2 cells. Infect Immun. 1995, 63: 4295-4300.PubMed CentralPubMed
- Lee A, O’Rourke JL, Barrington PJ, Trust TJ: Mucus colonization as a determinant of pathogenicity in intestinal infection by Campylobacter jejuni: a mouse cecal model. Infect Immun. 1986, 51: 536-546.PubMed CentralPubMed
- Yao R, Burr DH, Doig P, Trust TJ, Niu H, Guerry P: Isolation of motile and non-motile insertional mutants of Campylobacter jejuni: the role of motility in adherence and invasion of eukaryotic cells. Mol Microbiol. 1994, 14: 883-893. 10.1111/j.1365-2958.1994.tb01324.x.View ArticlePubMed
- Man SM, Kaakoush NO, Leach ST, Nahidi L, Lu HK, Norman J, Day AS, Zhang L, Mitchell HM: Host attachment, invasion, and stimulation of proinflammatory cytokines by Campylobacter concisus and other non-Campylobacter jejuni Campylobacter species. J Infect Dis. 2010, 202: 1855-1865. 10.1086/657316.View ArticlePubMed
- Guerry P, Ewing CP, Schirm M, Lorenzo M, Kelly J, Pattarini D, Majam G, Thibault P, Logan S: Changes in flagellin glycosylation affect Campylobacter autoagglutination and virulence. Mol Microbiol. 2006, 60: 299-311. 10.1111/j.1365-2958.2006.05100.x.PubMed CentralView ArticlePubMed
- Joshua GW, Guthrie-Irons C, Karlyshev AV, Wren BW: Biofilm formation in Campylobacter jejuni. Microbiology. 2006, 152: 387-396. 10.1099/mic.0.28358-0.View ArticlePubMed
- Jensen PO, Givskov M, Bjarnsholt T, Moser C: The immune system vs. Pseudomonas aeruginosa biofilms. FEMS Immunol Med Microbiol. 2010, 59: 292-305.PubMed
- Gunther NW, Chen CY: The biofilm forming potential of bacterial species in the genus Campylobacter. Food Microbiol. 2009, 26: 44-51. 10.1016/j.fm.2008.07.012.View ArticlePubMed
- Goon S, Kelly JF, Logan SM, Ewing CP, Guerry P: Pseudaminic acid, the major modification on Campylobacter flagellin, is synthesized via the Cj1293 gene. Mol Microbiol. 2003, 50: 659-671. 10.1046/j.1365-2958.2003.03725.x.View ArticlePubMed
- Golden NJ, Acheson DW: Identification of motility and autoagglutination Campylobacter jejuni mutants by random transposon mutagenesis. Infect Immun. 2002, 70: 1761-1771. 10.1128/IAI.70.4.1761-1771.2002.PubMed CentralView ArticlePubMed
- Kaakoush NO, Deshpande NP, Wilkins MR, Raftery MJ, Janitz K, Mitchell H: Comparative analyses of Campylobacter concisus strains reveal the genome of the reference strain BAA-1457 is not representative of the species. Gut Pathog. 2011, 3: 15-10.1186/1757-4749-3-15.PubMed CentralView ArticlePubMed
- Schneider WR, Doetsch RN: Effect of viscosity on bacterial motility. J Bacteriol. 1974, 117: 696-701.PubMed CentralPubMed
- Atuma C, Strugala V, Allen A, Holm L: The adherent gastrointestinal mucus gel layer: thickness and physical state in vivo. Am J Physiol Gastrointest Liver Physiol. 2001, 280: G922-G929.PubMed
- Corazziari ES: Intestinal mucus barrier in normal and inflamed colon. J Pediatr Gastroenterol Nutr. 2009, 48 (Suppl 2): S54-S55. 10.1097/MPG.0b013e3181a117ea.View ArticlePubMed
- Shigematsu M, Umeda A, Fujimoto S, Amako K: Spirochaete-like swimming mode of Campylobacter jejuni in a viscous environment. J Med Microbiol. 1998, 47: 521-526. 10.1099/00222615-47-6-521.View ArticlePubMed
- van Klinken BJ, Oussoren E, Weenink JJ, Strous GJ, Buller HA, Dekker J, Einerhand AW: The human intestinal cell lines Caco-2 and LS174T as models to study cell-type specific mucin expression. Glycoconj J. 1996, 13: 757-768. 10.1007/BF00702340.View ArticlePubMed
- Hugdahl MB, Beery JT, Doyle MP: Chemotactic behavior of Campylobacter jejuni. Infect Immun. 1988, 56: 1560-1566.PubMed CentralPubMed
- McAuley JL, Linden SK, Png CW, King RM, Pennington HL, Gendler SJ, Florin TH, Hill GR, Korolik V, McGuckin MA: MUC1 cell surface mucin is a critical element of the mucosal barrier to infection. J Clin Invest. 2007, 117: 2313-2324. 10.1172/JCI26705.PubMed CentralView ArticlePubMed
- Tu QV, McGuckin MA, Mendz GL: Campylobacter jejuni response to human mucin MUC2: modulation of colonization and pathogenicity determinants. J Med Microbiol. 2008, 57: 795-802. 10.1099/jmm.0.47752-0.View ArticlePubMed
- Kaakoush NO, Man SM, Lamb S, Raftery MJ, Wilkins MR, Kovach Z, Mitchell H: The secretome of Campylobacter concisus. FEBS J. 2010, 277: 1606-1617. 10.1111/j.1742-4658.2010.07587.x.View ArticlePubMed
- Donlan RM: Biofilms: microbial life on surfaces. Emerg Infect Dis. 2002, 8: 881-890. 10.3201/eid0809.020063.PubMed CentralView ArticlePubMed
- Reuter M, Mallett A, Pearson BM, van Vliet AH: Biofilm formation by Campylobacter jejuni is increased under aerobic conditions. Appl Environ Microbiol. 2010, 76: 2122-2128. 10.1128/AEM.01878-09.PubMed CentralView ArticlePubMed
- Anderson GG, Palermo JJ, Schilling JD, Roth R, Heuser J, Hultgren SJ: Intracellular bacterial biofilm-like pods in urinary tract infections. Science. 2003, 301: 105-107. 10.1126/science.1084550.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.